Animas IPO: Insulin Pump Maker Offers Up To $69 Mil. In Stock

Proceeds from Animas Corp.'s initial public offering will support sales and marketing of the IR 1200 third-generation insulin pump and evaluation of continuous glucose sensor technology licensed from Thomas Jefferson University, the manufacturer notes

More from Archive

More from Medtech Insight